Isherwood: Eli Lilly ‘Very Well Positioned’ as Investors Spot Potential

Bullish Gator

Ryan Isherwood of Significance Capital explains why Eli Lilly is ‘very well positioned’ and how investors are recognizing its healthcare growth potential.

Editorial companion

What stands out

On BNN Bloomberg, Ryan Isherwood called Eli Lilly "very well positioned" and said investors are beginning to recognize that potential, a clip worth noting because it signals institutional appetite for big pharma growth stories beyond the usual biotech noise. Isherwood is founder and CIO at Significance Capital Management and was pitching healthcare Hot Picks, which makes his endorsement less casual than a cable soundbite. For investors this is a reminder: strong fundamentals can attract fresh multiple expansion, but that attention often comes after much of the hard work is already priced in.